StockWatch
·
Q2 FY-2027 RESULTS · BEML

BEML PAT falls 31% YoY to ₹33 Cr despite 42% revenue growth; QoQ swing from loss to profit

PAT -30.6% YoY · revenue +42% · margins compressing

Q2 FY27 resultsBEMLBEML LTD.05 Nov 2026 · 3 min read
Revenue

₹1,191.61 Cr

+42% YoY

PAT (consolidated)

₹33.34 Cr

-30.6% YoY

Net margin

2.78%

-2.9pp YoY

EPS

₹4

BEML's consolidated PAT came in at ₹33.34 Cr for Q2 FY27, down 30.6% from ₹48.03 Cr in the year-ago quarter, even though consolidated revenue jumped 42.0% YoY to ₹1,191.61 Cr from ₹839.09 Cr — profit trailing revenue YoY means this quarter's story is margin compression, not growth. Sequentially it looks better: the company swung from a ₹27.01 Cr consolidated loss in Q1 FY27 to this quarter's profit, on a 45.4% QoQ revenue jump. Standalone PAT of ₹32.93 Cr (EPS ₹3.95) tracks closely with the consolidated print (EPS ₹4.00), so both bases tell the same story. No exceptional items appear in the current, sequential or year-ago columns, so both the YoY decline and the QoQ turnaround are purely operational, not one-off driven.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,191.61 Cr+45.4%+42%
Expenses₹1,150.39 Cr+34.6%+44.6%
PAT₹33.34 Cr—-30.6%
Net margin2.78%+6.1pp-2.9pp
EPS₹4+23.5%-65.3%

Net profit margin compressed to 2.80% from 5.68% a year ago (even as it improved from -3.29% in Q1). The squeeze sits on the cost-of-materials line: material and bought-out cost rose to 60.8% of revenue from 56.9% a year ago, offsetting a drop in employee costs to 18.3% of revenue from 24.3% as fixed costs spread over a larger revenue base. On an EBITDA basis (PBT plus finance cost and depreciation), the margin works out to roughly 7.2% of revenue this quarter — well short of the "sustainable 16% EBITDA margin" management guided to on the Q1 FY27 call, so on profitability the quarter missed the bar management itself set even as revenue outpaced it.

₹
1,615.991,759.651,903.32,046.952,190.612,052.508-0308-2509-1710-1211-0411-05Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹2,052.5, up 0.5% over the past month of trading.

₹ Cr
-93.387.44108.27209.1-64.11Q1 FY26rev ₹634 Cr48.03Q2 FY26rev ₹839 Cr-22.38Q3 FY26rev ₹1,083 Cr179.82Q4 FY26rev ₹1,794 Cr-27.01Q1 FY27rev ₹820 Cr33.34Q2 FY27rev ₹1,192 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (1 FY-2027 call)
Management projected sustainable EBITDA margins of 16% with a breakeven at ₹4,000 Cr revenue. Actual Q1 FY-2027 delivered 0.2% OPM and -3.3% NPM (₹27 Cr loss). Order book target of ₹24,000 Cr by year-end (from ₹15,900 Cr base + ₹6,000+ Cr inflow) stated; capex and R&D at all-time highs.

— This quarter: missed

Management's Q1 FY27 commentary had flagged a negative short-term outlook, a concerned tone, and pegged EBITDA breakeven near ₹4,000 Cr of annualised revenue — H1 FY27 consolidated revenue of ₹2,011 Cr (annualising to ~₹4,022 Cr) sits right at that threshold, yet margins remain far below the stated 16% target. Separately, the Chairman had guided to roughly 30% revenue growth for FY27; H1 revenue is up 35.1% YoY, tracking ahead of that goal even as the margin promise lags. No analyst consensus estimate for this specific quarter turned up in a search (results were declared the same day, so previews had not yet circulated), so vsStreet is unknown; no company press release was available in the context to cross-check management's own framing. On orders, the quarter saw a ₹5,400 Cr NHSRCL rolling-stock win (Sep 18) and a ₹75.58 Cr HMV export order (Oct 9), building toward the ₹24,000 Cr FY27-end order-book target flagged off a ~₹15,900-16,284 Cr base — though this filing carries no consolidated order-book total (segment disclosure is MCA-exempted), so the exact progress figure can't be confirmed from the result itself.

  • W1

    Whether EBITDA margin (~7.2% this quarter) closes the gap to management's guided 'sustainable 16%' target in coming quarters

  • W2

    Order-book progress toward the stated ₹24,000 Cr FY27 year-end target (from the ~₹15,900-16,284 Cr base cited post-Q1)

  • W3

    Whether Q2's QoQ revenue/profit recovery (after Q1's loss) sustains into Q3 FY27 or proves a one-quarter bounce

Source figures in ₹ Lakh, converted ÷100 to ₹ Cr; no exceptional items in current, sequential, or year-ago columns on either basis; standalone PAT ₹32.93 Cr vs consolidated ₹33.34 Cr is a <2% divergence (consolidated includes ₹0.01 Cr NCI share); scan is clean and legible, column headers unambiguous.

Informational and educational content only. Not investment advice.